Aspen Pharmacare’s CEO, Stephen Saad, has celebrated the company’s new licensing agreement to enter the rapidly expanding GLP-1 agonist market. He said this milestone marks a “significant coup” for the company, enabling it to prepare for the market by 2026 and...
According to a recent World Health Organisation report, tuberculosis (TB) has become the leading cause of infectious disease-related deaths in 2023, overtaking COVID-19. With over 8.2 million new TB diagnoses – the highest recorded since monitoring began in 1995...
Since emerging from apartheid three decades ago, South Africa has worked to ensure access to healthcare, food, and social assistance, as promised in the 1996 Constitution’s Bill of Rights. Yet, despite investments, the public healthcare system remains hampered by...
As healthcare costs soar, Clicks’ customers increasingly choose generic medications because they are affordable. Sales of generics, including Clicks-branded and other pharmaceutical brands, grew by 10% in the year to August 2024. Generics comprise 59% of Clicks’...
Dis-Chem Pharmacies has reported strong financial results for the first half of 2024, showcasing a 16.3% increase in headline earnings per share (HEPS). The group’s focus on expansion and efficient cost management has significantly boosted its bottom line. Dis-Chem...
